Maisonneuve-Rosemont Hospital Research Center and Department of Ophthalmology, University of Montreal, Montreal, Canada.
Invest Ophthalmol Vis Sci. 2010 Apr;51(4):2011-8. doi: 10.1167/iovs.09-4021. Epub 2009 Sep 24.
Purpose. Optic nerve injury causes loss of retinal ganglion cells (RGCs) and their axons. The reduction in RGC counts over time in axonal injury is well studied, but the correlation with the timing of anterograde and retrograde axonal degeneration is less clear. The authors longitudinally imaged RGC axons stained with a chloromethyl derivative of fluorescein diacetate (CMFDA) in live rats after optic nerve injury. Methods. Optic nerves were transected. Three days later CMFDA was intravitreously injected. Confocal scanning laser ophthalmoscopy was performed daily, and mean fluorescence intensity and the number of CMFDA bundles were calculated. RGC soma survival was studied after retrograde fluorescence labeling. Retinal nerve fiber layer (RNFL) thickness was evaluated histologically. Results. CMFDA-positive RGC axon bundles could be imaged in vivo. Axons lost 68% +/- 29% of their fluorescence by 7 days after transection compared with 25% +/- 21% in nontransected eyes. The number of labeled axon bundles decreased by 61% +/- 28% at 7 days after transection compared with 26% +/- 9% in nontransected eyes. The number of retrograde-labeled RGCs detected in vivo declined by 53% at 7 days and by 76% at 14 days after transection. RGC soma and CMFDA axon counts decreased most rapidly between 5 and 7 days after transection. Histologic examination demonstrated a reduction in RNFL thickness 7 days after transection. Conclusions. Intravitreal CMFDA can be used to longitudinally monitor RGC axons within the RNFL in vivo. Imaging the disappearance of retrograde-labeled RGC somas and axons indicates that axonal and somal degeneration occur in parallel after axotomy.
视神经损伤会导致视网膜神经节细胞(RGCs)及其轴突丧失。轴突损伤后 RGC 计数随时间减少的情况已得到充分研究,但与顺行和逆行轴突变性的时间相关性尚不清楚。作者在活体大鼠视神经损伤后用荧光素二乙酸酯的氯甲基衍生物(CMFDA)对 RGC 轴突进行了纵向成像。
视神经被横断。3 天后,将 CMFDA 经玻璃体内注射。每天进行共焦扫描激光检眼镜检查,计算平均荧光强度和 CMFDA 束的数量。用逆行荧光标记研究 RGC 体存活情况。用组织学评估视网膜神经纤维层(RNFL)厚度。
CMFDA 阳性 RGC 轴突束可以在体内成像。与未横断眼相比,横断后 7 天,轴突失去 68% +/- 29%的荧光,而非横断眼为 25% +/- 21%。横断后 7 天,标记的轴突束数量减少 61% +/- 28%,而非横断眼为 26% +/- 9%。在横断后 7 天和 14 天,体内检测到的逆行标记 RGC 数量分别下降了 53%和 76%。RGC 体和 CMFDA 轴突计数在横断后 5 至 7 天内下降最快。组织学检查显示,横断后 7 天 RNFL 厚度减少。
玻璃体内 CMFDA 可用于在体纵向监测 RNFL 内的 RGC 轴突。对逆行标记的 RGC 体和轴突消失的成像表明,轴突切断后轴突和体同时发生变性。